Betaxolol

Product NDC: 17478-705
11-digit product format: 174780705
Labeler code: 17478
Product ID: 17478-705_279440fe-a010-49be-98bc-bfa70a222438
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Betaxolol Hydrochloride
Dosage form: SOLUTION/ DROPS
Route: OPHTHALMIC
Labeler: Akorn
Application: ANDA075386
Marketing category: ANDA
Marketing start: 2003-04-01
Marketing end: 0000-00-00
Substance: BETAXOLOL HYDROCHLORIDE
Active strength: 5 mg/mL
Pharmacologic classes: Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	17478-705		I	Inactivated by FDA	2026-08-10
excluded package	package	17478-705	17478-705-10	I	Inactivated by FDA	2026-08-10
excluded package	package	17478-705	17478-705-11	I	Inactivated by FDA	2026-08-10
excluded package	package	17478-705	17478-705-12	D	Discontinued by firm	2026-08-10
excluded package	package	17478-705	17478-705-25	D	Discontinued by firm	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 69 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-705-25	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-705-11	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-705-12	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-705-10	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-705-25	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-705-11	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-705-12	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-705-10	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-705-25	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-705-11	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-705-12	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-705-10	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-705-25	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-705-11	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-705-12	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-705-10	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-705-25	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-705-11	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-705-12	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-705-10	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-705-25	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-705-11	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-705-12	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-705-10	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-705-25	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-705-11	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-705-12	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-705-10	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-705-25	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-705-11	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-705-12	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-705-10	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-705-25	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-705-11	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-705-12	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-705-10	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-705-25	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-705-11	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-705-12	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-705-10	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-705-25	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-705-11	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-705-12	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-705-10	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-705-25	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-705-11	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-705-12	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-705-10	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075386-001	BETAXOLOL HYDROCHLORIDE	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC			2000-06-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC		2000-06-30	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A075386-001	BETAXOLOL HYDROCHLORIDE	EQ 0.5% BASE	SOLUTION/DROPS / OPHTHALMIC	AT	2000-06-30	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075386-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075386-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075386-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075386-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075386-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075386-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075386-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075386-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075386-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075386-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075386-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075386-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075386-001	AT	1	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	A075386-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075386-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075386-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A075386-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A075386-001	AT	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
17478-705-10	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55
17478-705-11	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55
17478-705-12	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55
17478-705-25	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17478-705-10	Betaxolol	1 in 1 CARTON	SOLUTION/ DROPS	1	5
17478-705-10	Betaxolol	5 mL in 1 VIAL	SOLUTION/ DROPS	5	5
17478-705-11	Betaxolol	1 in 1 CARTON	SOLUTION/ DROPS	1	5
17478-705-11	Betaxolol	10 mL in 1 VIAL	SOLUTION/ DROPS	10	5
17478-705-12	Betaxolol	15 mL in 1 VIAL	SOLUTION/ DROPS	15	5
17478-705-12	Betaxolol	1 in 1 CARTON	SOLUTION/ DROPS	1	5
17478-705-25	Betaxolol	2.5 mL in 1 VIAL	SOLUTION/ DROPS	2.5	5
17478-705-25	Betaxolol	1 in 1 CARTON	SOLUTION/ DROPS	1	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17478-705-10	ML - Milliliter	17478-705	6a611f71-acdc-46c6-9ddb-98fcf37ba7de	1	2012-07-24
17478-705-11	ML - Milliliter	17478-705	ecb50b52-9bd1-4cab-8830-e6a2e5c634a9	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Betaxolol Hydrochloride	ACTIVE INGREDIENT	6X97D2XT0O	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1
Betaxolol	ACTIVE MOIETY	O0ZR1R6RZ2	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1
Benzalkonium Chloride	INACTIVE INGREDIENT	F5UM2KM3W7	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17478-705	BETAXOLOL (BETAXOLOL HYDROCHLORIDE) SOLUTION/ DROPS [AKORN]	5	Legacy NDC, 8 package rows	20220524_1fc0a413-4e6b-4ed7-9957-ace4c8cfab55.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6X97D2XT0O	BETAXOLOL HYDROCHLORIDE	63659-19-8	BETAXOLOL HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308720	betaxolol HCl 0.5 % Ophthalmic Solution	PSN	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55	5
308720	betaxolol 5 MG/ML Ophthalmic Solution	SCD	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55	5
308720	betaxolol 0.5 % Ophthalmic Solution	SY	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55	5
308720	betaxolol 5 MG/ML (betaxolol hydrochloride 5.6 MG/ML) Ophthalmic Solution	SY	1fc0a413-4e6b-4ed7-9957-ace4c8cfab55	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
17478-705-10	17478070510	1 VIAL in 1 CARTON (17478-705-10) > 5 mL in 1 VIAL	1 vial	2003-04-01	0000-00-00	No	No	Current
17478-705-11	17478070511	1 VIAL in 1 CARTON (17478-705-11) > 10 mL in 1 VIAL	1 vial	2003-04-01	0000-00-00	No	No	Current
17478-705-12	17478070512	1 VIAL in 1 CARTON (17478-705-12) > 15 mL in 1 VIAL	1 vial	2003-04-01	0000-00-00	No	No	Current
17478-705-25	17478070525	1 VIAL in 1 CARTON (17478-705-25) > 2.5 mL in 1 VIAL	1 vial	2003-04-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Betaxolol - Akorn \| Akorn Operating Company LLC	Akorn \| Akorn Operating Company LLC	2022-05-23	HUMAN PRESCRIPTION DRUG LABEL	5